Category:
Active Pharmaceutical Ingredients
CAS NO:
852433-84-2
Standard:
In-house Standards,
Oncology
Dovitinib (CAS 297160-58-6) is a multi-targeted tyrosine kinase inhibitor primarily developed for oncology. Its core synthesis involves complex heterocyclic coupling to yield the target molecule C24H23N7O2.
Strictly for laboratory research only; not approved for human clinical use. Store under inert atmosphere at -20°C. Handle with PPE due to potential toxicity.